NEW YORK, August 11, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the following equities: Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Holdings Inc. (NYSE: EVHC), BioScrip Inc. (NASDAQ: BIOS), Perrigo Company PLC (NYSE: PRGO) and Neurocrine Biosciences Inc. (NASDAQ: NBIX). Free research report on Brookdale Senior Living can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=BKD. On Monday, August 10, 2015, the NASDAQ Composite ended at 5,101.80, up 1.15%, the Dow Jones Industrial Average advanced 1.39%, to finish the day at 17,615.17 and the S&P 500 closed at 2,104.18, up 1.28%. The gains were broad based as all the sectors ended the session in positive. Register for your complimentary reports at the links given below.
Brookdale Senior Living Inc.'s stock edged 0.14% higher, to close the day at $29.16. The stock recorded a trading volume of 2.88 million shares, above its three months average volume of 2.34 million shares. Over the last one month and over the past three months, Brookdale Senior Living Inc.'s shares have declined 13.88% and 19.07%, respectively. Furthermore, the stock has lost 20.48% since the start of this year. The company's shares are trading 15.50% below their 50-day moving average. Additionally, Brookdale Senior Living Inc. has a Relative Strength Index (RSI) of 18.85. Sign up and read the free notes on BKD at:
On Monday, shares in Envision Healthcare Holdings Inc. recorded a trading volume of 1.58 million shares, lower than their three months average volume of 1.75 million shares. The stock ended the day 0.63% higher at $44.38. Shares of the company traded at a PE ratio of 44.83. Envision Healthcare Holdings Inc.'s stock has surged 13.85% in the last one month, 22.94% in the previous three months and 27.93% on YTD basis. The company is trading above its 50-day and 200-day moving averages by 12.18% and 19.84%, respectively. Furthermore, shares of Envision Healthcare Holdings Inc. have an RSI of 71.07. The complimentary notes on EVHC can be downloaded in PDF format at:
BioScrip Inc.'s stock plummeted 22.39%, to close Monday's session at $2.08. The stock recorded a trading volume of 4.20 million shares, much above its three months average volume of 1.19 million shares. Over the last one month and the previous three months, BioScrip Inc.'s shares have declined 31.58% and 47.61%, respectively. Additionally, the stock has plummeted 70.24% since the start of this year. The company is trading 35.67% and 57.51% below its 50-day and 200-day moving averages, respectively. Furthermore, BioScrip Inc.'s stock has an RSI of 27.16. Register for free on Equity Research Institute and access the latest research on BIOS at:
Perrigo Co. PLC's stock finished Monday's session 1.99% higher at $193.99. A total of 0.77 million shares were traded, which was below its three months average volume of 1.15 million shares. Over the last one month and the previous three months, Perrigo Co. PLC's shares have advanced 7.26% and 0.28%, respectively. Additionally, the stock has gained 16.22% since the beginning of 2015. The company's shares are trading above their 50-day and 200-day moving averages by 3.14% and 12.33%, respectively. Perrigo Co. PLC's stock traded at a PE ratio of 129.33 and has an RSI of 60.12. The complete research on PRGO is available for free at:
On Monday, shares in Neurocrine Biosciences Inc. ended the session 0.47% lower at $46.25. The stock reported a trading volume of 0.63 million shares, below its three months average volume of 0.87 million shares. Although, Neurocrine Biosciences Inc.'s shares have lost 3.97% in the last one month, it has surged 16.70% in the previous three months and 107.03% on YTD basis. The company is trading 28.92% above its 200-day moving average. Moreover, shares of Neurocrine Biosciences Inc. have an RSI of 40.19. Free in-depth research on NBIX is available at:
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ERI has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
ERI has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA® have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA® (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
ERI, the Author, the Reviewer and the CFA® (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ERI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.equityresearchinstitute.com.
ERI is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.